Atlas Trials

Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy

Clinical trial NCT05805202 · RECRUITING

Trial details

NCT number
NCT05805202
Sponsor
Mario Negri Institute for Pharmacological Research
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Atypical Hemolytic Uremic Syndrome
Start date
2023-05-03
Primary completion
2026-12-31
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.